RxDoctor Payments Data

Sachin Kamath, MD

Radiation Oncology · Lady Lake, FLNPI 1013965359

Payments from drug & device makers

$8,961in general payments, 2019–2025

Across 439 payments — averaging $20.41 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Johnson & Johnson$1K
  • AstraZeneca$666
  • Novartis$653
  • Merck$614
  • Pfizer$535
  • Incyte Corporation$461
  • plus $5K from 54 others

What the payments were for

  • Speaking & faculty fees$5126%
  • Food & beverage$8,44994%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Johnson & Johnson59$1,147
AstraZeneca(2 entities)30$666
Novartis38$653
Merck34$614
Pfizer8$535
Incyte Corporation24$461
Daiichi Sankyo Inc.20$382
Amgen20$349
Eisai Inc.15$286
Bayer16$285
AbbVie9$239
Regeneron Healthcare Solutions, Inc.10$237
Gilead(2 entities)9$215
Seagen Inc.12$181
Takeda Pharmaceuticals U.S.A., Inc.7$169
Heron Therapeutics, Inc.9$134
Boehringer Ingelheim6$133
Beigene USA, Inc.8$128
Lilly USA, LLC5$126
Genentech USA, Inc.7$125
Zimmer Biomet1$120
Sanofi6$116
Array Biopharma Inc3$115
E.r. Squibb & Sons, L.L.C.8$111
GSK6$106
Octapharma USA, Inc.1$98
Astellas Pharma US Inc5$89
Ipsen Biopharmaceuticals, Inc6$85
Jazz Pharmaceuticals Inc.4$66
Pharmaessentia USA Corporation3$65
G1 Therapeutics, Inc.3$61
Dova Pharmaceuticals4$61
Dendreon Pharmaceuticals LLC3$60
Agios Pharmaceuticals, Inc.4$56
Stemline Therapeutics Inc.2$53
AVEO Pharmaceuticals, Inc.3$48
Sobi, Inc2$43
Aurobindo Pharma USA, Inc.2$42
EMD Serono, Inc.2$42
Rigel Pharmaceuticals, Inc.1$37
Foundation Medicine, Inc.1$33
Tersera Therapeutics LLC2$31
Legend Biotech USA Inc.2$30
Clovis Oncology, Inc.2$27
Telix Pharmaceuticals1$23
Pharmacosmos Therapeutics Inc.1$23
Iovance Biotherapeutics, Inc.1$22
Karyopharm Therapeutics Inc.1$21
Beone Medicines USA, Inc.1$20
Recordati_rare_diseases_inc.1$19
Genmab U.S., Inc.1$19
Tolmar Pharmaceuticals, Inc.1$19
Exelixis Inc.1$18
Adaptive Biotechnologies Corporation1$16
Blueprint Medicines Corporation1$16
Pharmacyclics LLC, An Abbvie Company1$16
Emmaus Medical, Inc.1$15
Mirati Therapeutics, Inc.1$14
Verastem, Inc.1$14
Global Blood Therapeutics, Inc.1$14

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$8,961 in reported general payments places this provider in the 80th percentile of 465 radiation oncology providers in Florida.

See all radiation oncology providers in Florida

Medicare billing

Part B allowed, 2024
$6,157,741
Medicare patients
811
Services billed
77,411

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Memantine Hcl30$1,325
Dexamethasone38$1,159
Methylprednisolone85$723
Lidocaine Hcl ViscousLidocaine Hcl37$464
Ondansetron OdtOndansetron16$423
Tamsulosin Hcl48$268

Paid to pharmacies, not to this prescriber.

Other radiation oncology in Lady Lake

See the full list for Florida

Where these figures come from

Is this you, or does something look wrong? →